In the Press
February 24, 2016
Emphasizing Collaboration at a Pivotal Moment in Cancer Research: Ida Deichaite's opinion article in Xconomy San Diego features the 12th Moores Cancer Center Industry/Academic Translational Oncology Symposiumn on February 25 and the current cancer therapy landscape.
2016 Symposium: Save the Date!
Our 12th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium will be held on Thursday February 25, 2016. Learn more about the symposium and presentation topics here.
Polyvalent vaccines targeting oncogenic driver pathways
Nora Disis, MD
Fred Hutchinson Cancer Research Center
Associate Dean for Translational Science
University of Washington School of Medicine
Molecular diversity of human breast cancer: biologic and therapeutic implications
Dennis Slamon, MD, PhD
UCLA Jonsson Comprehensive Cancer Center
Please note: Additional speakers will be announced as they are confirmed.
Translational studies of KTN3379, a novel anti-ErbB3 antibody
Diego Alvarado, PhD
Immuno-Oncology: Rational combination therapy
Chris Boshoff, MD, PhD
Compound development of LADD therapeutics in prostate and lung cancer
Robert Charnas, PhD
Lung cancer KRAS addiction is reversed by disrupting an integrin/lectin membrane complex
David Cheresh, PhD
The role of MET exon14 deletion mutations as driver oncogenes in patients with NSCLC and therapeutic intervention with the prototype MET inhibitor glesatinib
Jamie Christensen, PhD
Ezra Cohen, MD
Monitoring daily dynamics of early tumor response to targeted therapy in lung cancer
Hatim Husain, MD
Mark Erlander, PhD
The role of the microenvironment in modulating tumor angiogenesis
Napoleone Ferrara, MD
Targeting the PI3K-mTOR signaling circuitry in cancer: a bridge from bench to clinic
J. Silvio Gutkind, PhD
Detection and targeting of malignant niche mediated cancer stem cell generation
Catriona Jamieson, MD, PhD
Bone microenvironment and drug resistance
Christina Jamieson, PhD
Anti-cancer therapies derived from human pluripotent stem cells
Dan Kaufman, MD, PhD
In the wake of homologous repair deficiency: Identifying PARP inhibitor responsive patients
Keith Mikule, PhD
Comprehensive genomic profiling of sarcomas in 175 adolescents and young adults reveals a distinct spectrum of targetable genomic alterations
Deborah Morosini, MD
Partnering with patients to accelerate the pace of biomedical research
Corrie Painter, PhD
Broad Institute of MIT and Harvard
Biomarker analysis and clinical response in patients with B-cell malignancies treated with anti-CD19 CAR T-cell therapy
Tony Polverino, PhD
Anti-ErbB3 therapies – what do we know to date
Birgit Schoeberl, PhD
Towards personalized immunotherapy of HNSCC
Stephen Schoenberger, PhD
Head of Cancer Vaccines, Human Longevity Inc.
Revisiting matrix metalloproteinases: allosteric inhibition of MMP9 using a monoclonal antibody
Victoria Smith, PhD
2015 Symposium Slideshow
Thank you to all that came and participated in the 2015 Symposium - we hope you enjoy the memories!
Our 11th Annual Moores Cancer Center Industry/Academia Translational Oncology Symposium took place on Thursday February 19, 2015.
Brian Druker, MD
OHSU Knight Cancer Institute
Presented by Rep. Scott Peters, Congressman
Awarded to Brian Druker, MD, OHSU Knight Cancer Institute
Elaine Mardis, PhD
The Genome Institute
Washington University School of Medicine
Rep. Scott Peters, Congressman
Bob Klein, Klein Financial Corporation
2014 Translational Oncology Symposium
A decade of fostering collaborations, fueling innovation & saving lives
San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Heather Clark, a patient of Moores Cancer Center, along with Ida Deichaite, Director of Industry Relations & Symposium Organizer, in a video report about the I-SPY Clinical Trial and Symposium. The I-SPY Clinical Trial is lead by Symposium Keynote Speaker and Principle Investigator Laura Esserman, MD, MBA. For the video, see below.
The article is available here.
9th Symposium Featured on San Diego ABC 10 News
San Diego ABC 10 News reporter Michael Chen interviewed San Diego resident Linda Lowe, a patient of Moores Cancer Center Investigator Dr. Catriona Jamieson, along with Moores Cancer Center Director of Industry Relations Ida Deichaite, PhD , in a video report from the 6PM News on April 11 covering the successful 9th Industry/Academia Translational Oncology Symposium.